Friedrich Asmus

Friedrich Asmus

Company: Oxular

Job title: Chief Medical Officer

Seminars:

Panel Discussion – Reviewing Efficacy of Administration Routes for Different Therapeutic Modalities Targeting Dry AMD & Geographic Atrophy 3:45 pm

Is subretinal a viable route for the delivery of therapeutics for dry AMD? Surgical complications associated with intravitreal and subretinal deliveries Moving towards outpatient delivery for better treatment turnoverRead more

day: Day Two

Routine Suprachoroidal Drug Administration: the Role in Intermediate AMD/GA Therapies 3:15 pm

Choroidal administration of therapies in intermediate AMD/GA Novel principle of targeted routine drug suprachoroidal administration Case studies: Use of the suprachoroidal Oxulumis® illuminated microcatheter in back-of-the-eye disordersRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.